NCT06679894

Brief Summary

The goal of this observational study is to compare, within a cohort of patients requiring rehabilitation in two different sites of the premolar area in the upper maxilla, the primary and secondary stability of implants placed in sites prepared using a magnetic mallet and osseodensification burs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 8, 2024

Completed
Last Updated

November 8, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

November 5, 2024

Last Update Submit

November 5, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Implant primary stability

    Insertion torque

    At implant insertion

  • Implant primary stability

    Resonance frequency

    At implant insertion

Secondary Outcomes (7)

  • Implant secondary stability

    7 days after implant insertion

  • Implant secondary stability

    14 days after implant insertion

  • Implant secondary stability

    21 days after implant insertion

  • Implant secondary stability

    28 days after implant insertion

  • Implant secondary stability

    60 days after implant insertion

  • +2 more secondary outcomes

Other Outcomes (3)

  • Peri-implant marginal bone level stability

    Immediately after surgery

  • Peri-implant marginal bone level stability

    Upon delivery of prosthetic rehabilitation (6 months after surgery)

  • Peri-implant marginal bone level stability

    One year of loading

Study Arms (2)

Single tooth edentulism right

single missed teeth

Procedure: Implant site preparation with osteotomes and electrified mallet

single tooth edentulism left

single missed tooth

Procedure: Implant site preparation with osseodensification drills

Interventions

Under local anesthesia (mepivacaine HCL 2% with epinephrine1:100.000), a minimally invasive full-thickness flap was elevated to expose the alveolar crest. A pilot osteotome (100-P) was used to easily perforate the cortical plate. Subsequently, osteotomes with gradually increasing diameters were employed until the final diameter of 3.2 mm was reached. The sequence of osteotomes and their respective diameters were as follows: 1. Osteotome 100-P: At a height of 8.5 mm, the diameter was 2.2 mm; 2. Osteotome 160: At a height of 8.5 mm, the diameter was 2.8 mm; 3. Osteotome 200: At a height of 8.5 mm, the diameter was 3.2 mm. Implant (4.0x8.5 mm; Anyridge, Megagen, Gyeongbuk, South Korea) was positioned using a surgical motor. A 3 mm high transepithelial abutment (OCTA, Megagen, Gyeongbuk, South Korea) was connected to it using a torque wrench and it was tightened to 30 Ncm. Single sutures in monofilament synthetic polypropylene 4.0 were performed to close flaps around the abutment.

Single tooth edentulism right

Under local anesthesia (mepivacaine HCL 2% with epinephrine1:100.000), a minimally invasive full-thickness flap was elevated to expose the alveolar crest. The implant site preparation was realized using osseodensification burs at a rotation speed of 1200 rpm. The osseodensification burs sequence was as follows: 1. Initial pilot hole (rotated clockwise); 2. WT1828 bur (rotated counterclockwise), 3. WT2838 bur (rotated counterclockwise). Implant (4.0x8.5 mm; Anyridge, Megagen, Gyeongbuk, South Korea) was positioned using a surgical motor. A 3 mm high transepithelial abutment (OCTA, Megagen, Gyeongbuk, South Korea) was connected to it using a torque wrench and it was tightened to 30 Ncm. Single sutures in monofilament synthetic polypropylene 4.0 were performed to close flaps around the abutment.

single tooth edentulism left

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

After investigating general and local anamnesis, which included evaluation of systemic illnesses and potential allergies, a dental visit was conducted to formulate a specific treatment plan. If the patient was deemed eligible for the research protocol, an additional periapical radiograph was obtained for each selected site to assess the adequacy of residual bone height. If the available bone height appeared to be sufficient, a second-level radiographic exam, a Cone Beam Computed Tomography (CBCT), was performed to evaluate whether the bone volume was adequate for supporting implant rehabilitation. For patients requiring tooth extraction, this second assessment was performed after six months of healing after extraction.

You may qualify if:

  • Age older than 18 years old;
  • Indication for an implant-supported rehabilitation in the upper premolar / first molar areas;
  • The area in which the implants will be placed must have had at least 6 months of healing;
  • No use of grafts or bone substitutes following tooth extraction;
  • Bone volume measuring at least 10 mm in height and 6 mm in width;
  • In case of two adjacent implants the distance between the natural teeth must be at least 14 mm, composed by twice the width of each implant (4 mm), the distance between them (at least 3 mm) and twice the distance between each teeth (at least 1,5 mm)
  • Bone quality belonging to class D3 or D4, following Misch classification
  • Absence or decision to not wear a removable prosthesis during the healing period;
  • Patients with good and stable oral hygiene;
  • Signed informed consent form.

You may not qualify if:

  • Acute myocardial infarction within the previous six months;
  • Uncontrolled bleeding disorders;
  • Uncontrolled diabetes (HBA1c \> 7.5%);
  • Radiotherapy in the head-neck area in the previous 48 months;
  • Immunocompromised patients (es. AIDS / chemotherapy);
  • Current or previous treatment with antiresorptive drugs via intravenous injection;
  • Psychological or psychiatric disease;
  • Alcohol and /or drugs abuse;
  • Heavy smokers (more than 10 cigarettes / day);
  • Plaque index \>20% and/or bleeding on probing \>10%
  • Pregnant or breastfeeding patients;
  • Patients refusing to participate in follow-up checks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Piezosurgery Academy

Parma, Italy, 43100, Italy

Location

MeSH Terms

Conditions

Mouth, EdentulousAlveolar Bone Loss

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesTooth DiseasesBone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2024

First Posted

November 8, 2024

Study Start

February 15, 2024

Primary Completion

July 15, 2024

Study Completion

November 5, 2024

Last Updated

November 8, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations